The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 6 results:
Author Title [ Type(Desc)] Year
Filters: Author is Markantonatou, Anthi-Marina  [Clear All Filters]
Journal Article
Markantonatou, A-M., Samaras K., Yannaki E., Zachrou E., & Vyzantiadis T-A. (2019).  Aspergillus galactomannan detection: Trichoderma as a cause of positive results.. Curr Microbiol. 76(1), 48-51.
Papadopoulou, A., Alvanou M., Koukoulias K., Athanasiou E., Lazaridou A., Savvopoulos N., et al. (2019).  Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.. Bone Marrow Transplant. 54(12), 1963-1972.
Markantonatou, A-M., Samaras K., Zachrou E., & Vyzantiadis T-A. (2020).  Comparison of Four Methods for the Susceptibility Testing of Dermatophytes.. Front Microbiol. 11, 1593.
Papadopoulou, A., Alvanou M., Koukoulias K., Athanasiou E., Lazaridou A., Savvopoulos N., et al. (2019).  Correction to: Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.. Bone Marrow Transplant. 54(12), 2120.
Kyrgios, I., Giza S., Kotanidou E. P., Kleisarchaki A., Tsinopoulou V. Rengina, Papadopoulou A., et al. (2019).  l-selenomethionine supplementation in children and adolescents with autoimmune thyroiditis: A randomized double-blind placebo-controlled clinical trial.. J Clin Pharm Ther. 44(1), 102-108.
Markantonatou, A-M., Ioakimidou A., Arvaniti K., Manou E., Papadopoulos V., Kiriklidou P., et al. (2017).  Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.. Mycoses. 60(10), 626-633.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.